Wednesday, 04 December 2024

  1. Poll
  2. Can mRNA technology prove to be beneficial for the Indian biopharma sector?

Poll

Can mRNA technology prove to be beneficial for the Indian biopharma sector?

Yes82%
82% Complete
No9%
9% Complete
May be9%
9% Complete
  More polls

Leadership

image credit- shutterstock

BioPharma’s Transformative & S...

Innovations in Urological Imag...
image credit- shutterstock

What’s dampening the Global AM...

Indian Lifesciences Industry G...
image credit- shutterstock

HIV Prevention Remains Elusive...

How strategic angel investment...

TRENDING TOPICS

image credit- shutterstock

Early Diabetic Retinopathy Det

Impact of Digital Transformati
image credit- pib

Govt announces launch of 4 CoE

PM inaugurates Lyfius Pharma’s





Most read

UCL and IISc join forces to co-crea

Medtronic launches US FDA approved

IIT Kharagpur partners with z21 Ven

Samsung R&D Institute, Noida and II

Survey Box

Is the Indian BioPharma sector ready for a Transformative & Strategic Outlook in 2025?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Subscribe to BioSpectrum India

Enquiry

Contact Us

MMA

Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045

Mob : +91-9579069369

Email : communications@mmactiv.com

**Disclaimer

Visit Our Digital Magazine :

BioSpectrum Asia

NuFFooDS Spectrum

Sitemap

© 2024 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer

Web Interface Conceived and Powered By : SCI Knowledge Interlinks